Aptevo Therapeutics
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2401 4th Ave Ste 1050, Seattle, Washingt...Phone Number
(206) 838-0500Website
www.aptevotherapeutics.comRevenue
-Stock Symbol
APVOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Aptevo Therapeutics
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.Explore more
Aptevo Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptevo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aptevo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aptevo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aptevo Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Aptevo Therapeutics had a recent Job posting/layoffs
Check out if Aptevo Therapeutics is spiking on competitors!
Product Launch: Get notified when Aptevo Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aptevo Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Aptevo Therapeutics
Recommended Actions
Find VP level buyers at Aptevo Therapeutics
Find 2 more new buyers
Compare Similar Companies to Aptevo Therapeutics
Compare insights from companies similar to Aptevo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
Aptevo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aptevo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aptevo Therapeutics.
Aptevo Therapeutics financials insights
Gather financial insights about Aptevo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$35M
2025
Other Financing Round
$2M
Share Placement
$2M
Aptevo Therapeutics Tech Stack
A closer look at the technologies used by Aptevo Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Business Finance, Finance, Financing & Debt
Person-Based
Clinical Operations
Person-Based
Clinical Operations
Person-Based
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Aptevo Therapeutics News & Media
Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market ... - Stock Titan
Biotech firm secures strategic funding for immune-oncology pipeline advancement. 2.3M shares at $0.862/share backs clinical development. Learn funding impact.Aptevo Therapeutics Secures $2.1M Strategic Financing Package | APVO Stock News
Biotech firm secures $2.1M through share offering at $1.19, includes strategic warrant component. Restructures existing warrants to strengthen capital position.Aptevo Therapeutics Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on ...
CEO Marvin White to showcase promising clinical results for Mipletamig AML treatment and solid tumor therapy ALG.APV-527 on Bloomberg's RedChip show.Certain Restricted Stock Units of Aptevo Therapeutics Inc. are subject to a Lock-Up ...
Certain Restricted Stock Units of Aptevo Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 30-SEP-2024. These Restricted Stock Units will be under lockup for 91 days starting from...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aptevo Therapeutics
Sign Up For FreeTo access detailed company insights
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative and proprietary ADAPTIR and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.... Read More
